Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros











Intervalo de ano de publicação
1.
Braz J Med Biol Res ; 38(2): 251-60, 2005 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-15785837

RESUMO

Serum antibodies specific for the capsular polysaccharides of Streptococcus pneumoniae provide protection against invasive pneumococcal infection. In Brazil, this vaccine has been used for people over 65 years with clinical risk to develop pneumococcal infection since 1999. We evaluated the immune response of 102 elderly subjects (75.5% females and 24.5% males) with a mean age of 71 years, and 19 young healthy adults (63.2% females and 36.8% males) with a mean age of 27 years. The elderly study group consisted of outpatients who received follow-up care in the Geriatric Department of General Hospital, Faculty of Medicine, University of São Paulo. None had acute illness at the time of vaccination. Both groups were immunized with one intra-deltoid injection with 0.5 ml of a 23-valent pneumococcal polysaccharide vaccine. The total IgG specific antibody concentrations to capsular polysaccharides 1, 3, 5, 6B, 8, and 14 were determined against pre- and 1-month post-vaccination sera. All samples were analyzed according to the second-generation pneumococcal polysaccharide ELISA protocol. We observed that the pneumococcal polysaccharide vaccine evoked consistent antibody increase for serotypes 1, 5, 6B, 8, and 14 (geometric mean concentration increase of 2.46 in the elderly and 2.84 in the young adults). Otherwise, we observed no increase in antibody concentration for serotype 3 in both groups.


Assuntos
Infecções Pneumocócicas/prevenção & controle , Vacinas Pneumocócicas/imunologia , Streptococcus pneumoniae/imunologia , Adulto , Fatores Etários , Idoso , Idoso de 80 Anos ou mais , Anticorpos Antibacterianos/imunologia , Brasil , Estudos de Casos e Controles , Ensaio de Imunoadsorção Enzimática , Feminino , Humanos , Imunoglobulina G/imunologia , Masculino , Pessoa de Meia-Idade
2.
Braz. j. med. biol. res ; 38(2): 251-260, fev. 2005. ilus, tab, graf
Artigo em Inglês | LILACS | ID: lil-393656

RESUMO

Serum antibodies specific for the capsular polysaccharides of Streptococcus pneumoniae provide protection against invasive pneumococcal infection. In Brazil, this vaccine has been used for people over 65 years with clinical risk to develop pneumococcal infection since 1999. We evaluated the immune response of 102 elderly subjects (75.5 percent females and 24.5 percent males) with a mean age of 71 years, and 19 young healthy adults (63.2 percent females and 36.8 percent males) with a mean age of 27 years. The elderly study group consisted of outpatients who received follow-up care in the Geriatric Department of General Hospital, Faculty of Medicine, University of São Paulo. None had acute illness at the time of vaccination. Both groups were immunized with one intra-deltoid injection with 0.5 ml of a 23-valent pneumococcal polysaccharide vaccine. The total IgG specific antibody concentrations to capsular polysaccharides 1, 3, 5, 6B, 8, and 14 were determined against pre- and 1-month post-vaccination sera. All samples were analyzed according to the second-generation pneumococcal polysaccharide ELISA protocol. We observed that the pneumococcal polysaccharide vaccine evoked consistent antibody increase for serotypes 1, 5, 6B, 8, and 14 (geometric mean concentration increase of 2.46 in the elderly and 2.84 in the young adults). Otherwise, we observed no increase in antibody concentration for serotype 3 in both groups.


Assuntos
Humanos , Masculino , Feminino , Adulto , Pessoa de Meia-Idade , Infecções Pneumocócicas/prevenção & controle , Vacinas Pneumocócicas/imunologia , Streptococcus pneumoniae/imunologia , Fatores Etários , Anticorpos Antibacterianos/imunologia , Brasil , Estudos de Casos e Controles , Ensaio de Imunoadsorção Enzimática , Imunoglobulina G/imunologia
3.
Rev Inst Med Trop Sao Paulo ; 43(3): 119-24, 2001.
Artigo em Inglês | MEDLINE | ID: mdl-11452318

RESUMO

We compared the results obtained by serotyping of PorB epitopes using an expanded panel of monoclonal antibodies (mAb) including mAb 7 and mAb 10, with results obtained by RFLP of rRNA genes (ribotyping). The purpose of this study was to assess the correlation between phenotypic- and genotypic- methods for typing N. meningitidis. The ribotypes obtained using ClaI or EcoRV endonucleases grouped the strains in seven and two different patterns, respectively. This additional characterization of PorB epitopes improved the correlation between these two methods of typing N. meningitidis.


Assuntos
Proteínas da Membrana Bacteriana Externa/genética , Neisseria meningitidis/genética , Porinas , Ribotipagem , Sorotipagem , Variação Genética , Humanos , Região Variável de Imunoglobulina/genética , Neisseria meningitidis/classificação
4.
Rev. bras. anal. clin ; 26(3): 91-3, 1994. tab, graf
Artigo em Português | LILACS | ID: lil-269368

RESUMO

Este trabalho tem como finalidade rever a etiologia da diarréia, e no qual pesquisamos todos os agentes da infecçäo intestinal, relacionados a seguir: E. coli enteropatogênica clássica (EPEC), E.coli enteroinvasora (EIEC), E.coli enterotoxigênica (ETEC), E.coli enterohemorrágica (EHEC), Shigella, Salmonella, Yersinia enterocolítica, Campylobacter, Aeromonas e Vibriocholerae


Assuntos
Humanos , Diarreia/etiologia , Disenteria Bacilar/microbiologia , Infecções por Campylobacter/microbiologia , Infecções por Escherichia coli/microbiologia , Enteropatias Parasitárias , Estudos Transversais , Infecções por Rotavirus/microbiologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA